PHG
Koninklijke Philips NV ADR
$30.51-1.77%
Setup
①BreakoutBreakout
Buy Zone
$27.77-$29.16
Sector
Medical Devices
Industry
Medical Devices
48
Recommendation
Extended
Avoid①
Setup may be valid but price is no longer in a clean buy zone.
PHG chart
Loading chart…
ADX
Weak or Absent11.9Long Term
Range →Intermediate Term
Range →Short Term
Range →Overall Quality48
RS Rating
47
relative strength
Fundamentals
56
Weak fund-Q
Volume Demand
68
+209% vs avg
Technical Setup
50
4/8 checks
Industry/Theme
91
Medical Devices
Trade Plan
Extended
Entry
$27.77
Entry Zone
$27.77-$29.16
Stop / Risk
$25.55
RS Rating
47
Volume confirmed
No
Targets
$33.32 / $34.71
Breakout · IBD Setup
2 ✓ 6 ✗
Entry $27.77–$29.16Stop $25.55Target $33.32 / $34.71
Market regimeRange
Quality48
RS Rating47
Above 50-MA+18.78%
Above 200-MA+12.13%
VolumeWeak
In Buy ZoneNo
Not extendedExtended
Invalidation · Close below stop
How this came together
48
MarketRange
Setup①BreakoutBreakout
ConfidenceMedium · 476 trades · 38% win · +0.30R
Fund-Q56 · Weak
StatusAvoid①
Stock Data
52-Week Range24 – 33
Price % Chg YTD12.67%
Price % Chg 4wk26.65%
50-Day Avg Vol1.0 Mil
P/E Ratio20.1
Market Cap$26B
SectorHealthcare
IndustryMedical Devices
Company Fundamentals
EPS % Chg (Qtr)62.15%
Sales % Chg (Qtr)3.1%
EPS Growth 5y-4.98%
Sales Growth 5y0.39%
Annual ROE10.24%
Gross Margin45.93%
Operating Margin9.12%
Net Margin6.3%
Debt / Equity0.65
Setup levels
Current price
$30.51
Pivot
$27.77
Distance to buy
-8.7%
52-week range
23.62-33.44
Trigger evidence
W double-bottom base
broke the middle peak 27.77 on volume ≥1.4×
Pattern levels: pivot 27.77
Financial health checks
3/5
Return on equity above 15%
ROE 10.24%
Net margin above 10%
Net margin 6.3%
EPS growing quarter on quarter
EPS q/q 62.15%
Sales growing quarter on quarter
Sales q/q 3.1%
Debt to equity below 1.0
D/E 0.65
Key metrics
Finviz snapshot · value vs. sector median (≥5 peers)
Annual ROE10.24%
vs sector -12.4%
Net margin6.3%
vs sector -11.4%
Gross margin45.93%
vs sector -21.2%
EPS growth q/q62.15%
vs sector +54.5%
Sales growth q/q3.1%
vs sector -15.6%
Debt / equity0.65
vs sector +0.00
Business quality
56
GradeWeak
EPS rating66
P/E20.1
Market cap$26B
IndustryMedical Devices
Technical checks
Über 50-MA
Pass
Über 200-MA
Pass
RS-Linie auf neuem Hoch
Fail
Volumen bestätigt
Fail
In Kaufzone
Fail
Nicht überextended
Fail
Über 21-EMA
Pass
Volumen gesund
Pass
IBD / source mentions
No recent IBD mention found for this ticker.
Signal history
Added to list
2026-10-28
Trigger date
—
Days on list
9
Data sources: internal CANSLIM engine · Finviz snapshot · TradingView chart. Not investment advice.